Bibliografia
Kim JY, Hong SM, Ro JY (2017) Recent updates on grading and classification of neuroendocrine tumors. Ann Diagn Pathol 29:11–16
Barrea L, Muscogiuri G, Modica R et al. (2021) Cardio-metabolic indices and metabolic syndrome as predictors of clinical severity of gastroenteropancreatic neuroendocrine tumors. Front Endocrinol 12:649496
Santos AP, Santos AC, Castro C et al. (2018) Visceral obesity and metabolic syndrome are associated with well-differentiated gastroenteropancreatic neuroendocrine tumors. Cancers 10(9):293–305
Author information
Authors and Affiliations
Corresponding author
Additional information
Nota della casa editrice
Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gaudenzi, G., Vitale, G. Indici cardio-metabolici e sindrome metabolica come predittori prognostici nei tumori neuroendocrini gastroenteropancreatici. L'Endocrinologo 23, 437–438 (2022). https://doi.org/10.1007/s40619-022-01142-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40619-022-01142-0